CVR 34083738Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Nordre Fasanvej 215, 2000 FrederiksbergFounded 15 Dec 2011
ACESION PHARMA ApS
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about ACESION PHARMA ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
16
CVR, Aug 2026
+2 (+14.3%) over 12 months
Result
-59.6M
DKK, group, annual report 2025
Equity
276.1M
DKK, group, annual report 2025
Novo Holdings A/SCVR 24257630, 33.3% to under 50% of capital and votes
Canaan XII L.P.20% to under 25% of capital and votes
and 2 moreOperating company
Dandex estimate: 16 employees registered in 2026Anders Gaarsdal Holstsince 1 Jun 2022
Owners of 5% or more. CVR registers shares in bands, not exact figures. All notified 22 Dec 2025.
CVR 2425763033.3% to under 50% of capital and votesclass Ordinære Anparter, Serie B Præference Anpartersince 16 Dec 2014
20% to under 25% of capital and votesclass Ordinære Anparter, Serie B Præference Anpartersince 15 Sep 2023
15% to under 20% of capital and votesclass Ordinære Anparter, Serie B Præference Anpartersince 15 Sep 2023
5% to under 10% of capital and votesclass Serie B Præference Anpartersince 20 Aug 2025
CVR 1005015410% to under 15% of capital and votesclass A, Bnotified 14 Oct 201617 Dec 2014 to 14 Oct 2016
CVR 340420125% to under 10% of capital and votesclass A, Bnotified 30 Sep 202014 Oct 2016 to 30 Sep 2020
5% to under 10% of capital and votesclass Bnotified 23 Jan 201917 Dec 2014 to 9 May 2022
5% to under 10% of capital and votesclass Bnotified 9 May 202212 May 2015 to 15 Sep 2023
5% to under 10% of capital and votesclass Bnotified 28 May 202123 Jan 2019 to 9 May 2022
5% to under 10% of capital and votesclass Ordinære Anparter4 Nov 2022 to 20 Aug 2025
Founded 15 Dec 2011.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 16 employees, 11 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 9 | 8 | 8 | 9 | 9 | 9 | 12 | 12 | 11 | 10 | 11 | 11 | 12 | 14 | 12 | 13 | 13 | 12 | 13 | 13 | 14 | 15 | 14 | 15 | 14 | 15 | 13 | 14 | 13 | 13 | 12 | 11 | 14 | 12 | 11 | 14 | 14 | 13 | 14 | 12 | 13 | 13 | 14 | 10 | 11 | 9 | 8 | 11 | 9 | 12 | 12 | 10 | 10 | 10 | 9 | 10 | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 13 | 12 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 12 | 11 | 12 | 11 | 13 | 12 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 11 | 11 | 11 | 10 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 12 | 12 | 12 | 12 | 10 | 9 | 9 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 14 | 14 | 13 | 14 | 15 | 14 | 14 | 14 | 15 | 16 | 16 | 16 | 15 | 15 | 15 | 16 |
| FTE | 1 | 2 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 5 | 5 | 7 | 7 | 6 | 6 | 7 | 8 | 8 | 9 | 8 | 9 | 9 | 8 | 9 | 9 | 9 | 10 | 9 | 10 | 9 | 11 | 9 | 11 | 9 | 9 | 8 | 8 | 9 | 8 | 8 | 9 | 8 | 9 | 9 | 8 | 9 | 9 | 11 | 7 | 7 | 6 | 6 | 7 | 6 | 9 | 9 | 7 | 7 | 7 | 6 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 10 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 9 | 8 | 8 | 9 | 9 | 9 | 10 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 11 | 11 | 12 | 12 | 11 | 11 | 11 |
| Series | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
Group figures (koncern), in DKK, from the annual reports filed in XBRL.
2025, DKK: Operating profit -71.3M, Result for the year -59.6M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 287.3M, Equity 276.1M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | Not reported | Not reported | Not reported | Not reported |
| Operating profit | -37,897 | -56,635 | -53,020 | -57,245 | -71,308 |
| Result for the year | -25,157 | -46,780 | -42,849 | -43,033 | -59,597 |
| Equity | 10,344 | 22,983 | 130,799 | 89,642 | 276,067 |
| Total assets | 33,954 | 53,191 | 165,939 | 116,146 | 287,308 |
| Employees (average) | 0 | 7 | 7 | 11 | Not reported |
Large listed filers report IFRS figures in an ESEF report, for the group where there is one.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 59,988,725, cash price 3.35, implied value 633,720,394 | 3.35 | 59,988,725 | 633,720,394 | 189,063,037 | |
| IncreaseCashPaid in 184,505,515, cash price 3.30, implied value 564,676,462 | 3.30 | 184,505,515 | 564,676,462 | 171,165,948 | |
| IncreaseCashPaid in 151,859,392, cash price 3.39, implied value 391,130,104 | 3.39 | 151,859,392 | 391,130,104 | 115,238,238 | |
| IncreaseConvertible notes, cashPaid in 57,250,000 | None | 57,250,000 | None | 70,496,070 | |
| IncreaseCash, debt conversionPaid in 54,917,355 | None | 54,917,355 | None | 13,246,070 | |
| IncreaseCashPaid in 14,881,486, cash price 21.95, implied value 180,588,986 | 21.95 | 14,881,486 | 180,588,986 | 8,225,977 | |
| IncreaseDebt conversionPaid in 10,908,344 | None | 10,908,344 | None | 7,548,114 | |
| IncreaseCashPaid in 37,334,462, cash price 22.00, implied value 150,755,396 | 22.00 | 37,334,462 | 150,755,396 | 6,852,518 |
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseDebt conversion, cashPaid in 20,762,574, cash price 20.00, implied value 103,109,940 | 20.00 | 20,762,574 | 103,109,940 | 5,155,497 | |
| IncreaseDebt conversion, cashPaid in 7,748,020, cash price 20.00, implied value 80,375,940 | 20.00 | 7,748,020 | 80,375,940 | 4,018,797 | |
| IncreaseDebt conversionPaid in 7,085,386 | None | 7,085,386 | None | 3,594,496 | |
| IncreaseCashPaid in 16,095,800, cash price 20.00, implied value 61,767,940 | 20.00 | 16,095,800 | 61,767,940 | 3,088,397 | |
| IncreaseCashPaid in 7,599,900, cash price 17.50, implied value 39,963,123 | 17.50 | 7,599,900 | 39,963,123 | 2,283,607 | |
| IncreaseDebt conversionPaid in 7,508,270 | None | 7,508,270 | None | 1,849,327 | |
| IncreaseCashPaid in 7,599,900, cash price 17.50, implied value 22,977,885 | 17.50 | 7,599,900 | 22,977,885 | 1,313,022 | |
| IncreaseCashPaid in 3,242,400, cash price 14.00, implied value 12,302,388 | 14.00 | 3,242,400 | 12,302,388 | 878,742 | |
| IncreaseCashPaid in 3,999,996, cash price 14.00, implied value 9,059,988 | 14.00 | 3,999,996 | 9,059,988 | 647,142 | |
| FoundingNot read from the announcement | None | None | None | 361,428 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
Group figures (koncern), in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 0 | 0 | 899 | 0 | 0 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
The newest 50 of 55 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 26.02.2026
Erhvervsstyrelsen skal hermed meddele, at der den 05.03.2026 er foretaget ændring i selskabets legale ejerforhold.
Ændringen vedrører erhvervelse af ordinære anparter
Vedtægter ændret: 22.12.2025
Kapitalforhøjelsen er besluttet den 22.12.2025.
kr. 8.403.090,00, indbetalt kontant, kurs 334,02. kr. 9.493.999,00, indbetalt kontant, kurs 336,22.
Kapitalen udgør herefter kr. 189.063.037,00.
Vedtægter ændret: 24.10.2025
Vedtægter ændret: 20.08.2025
Kapitalforhøjelsen er besluttet den 20.08.2025.
kr. 55.927.710,00, indbetalt kontant, kurs 329,90.
Kapitalen udgør herefter kr. 171.165.948,00.
Vedtægter ændret: 30.05.2024
Vedtægter ændret: 08.03.2024
Ny adresse: Nordre Fasanvej 215, 2000 Frederiksberg
Ny kommune: Frederiksberg
Vedtægter ændret: 15.09.2023
Kapitalforhøjelsen er besluttet den 15.09.2023.
kr. 44.742.168,00, indbetalt kontant, kurs 339,41.
Kapitalen udgør herefter kr. 115.238.238,00.
Kapitalen er opdelt i klasser.
Bestyrelse:
Fratrådte:
Morten Døssing, den 15.09.2023, Morten Grunnet, den 15.09.2023, Jørgen Søberg Petersen, (formand), den 15.09.2023, Karen Juo-Lai Chu, den 15.09.2023.
Tiltrådte:
Jørgen Søberg Petersen, (formand), den 15.09.2023, Nik Economopoulos, den 15.09.2023, Timothy Michael Shannon, den 15.09.2023.
Kapitalforhøjelsen er besluttet den 09.05.2022.
kr. 5.820.592,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 70.496.070,00.
Vedtægter ændret: 05.09.2022
Vedtægter ændret: 26.08.2022
Direktion:
Fratrådte:
Torgeir Vaage, den 01.06.2022.
Vedtægterne er yderligere ændret
Vedtægter ændret: 09.05.2022
Kapitalforhøjelsen er besluttet den 09.05.2022.
kr. 31.429.408,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 64.675.478,00.
Vedtægter ændret: 09.05.2022
Kapitalforhøjelsen er besluttet den 09.05.2022.
kr. 20.000.000,00, indbetalt ved ombytning af konvertible gældsbreve, kurs 100,00.
Kapitalen udgør herefter kr. 33.246.070,00.
Opdeling i kapitalklasser er ophævet.
Bestyrelse:
Fratrådte:
Ann Mills-Duggan, den 06.01.2022.
Vedtægter ændret: 28.05.2021
Kapitalforhøjelsen er besluttet den 28.05.2021.
kr. 1.943.813,00, indbetalt kontant, kurs 100,00. kr. 3.076.280,00, indbetalt ved konvertering af gæld, kurs 1.722,00.
Kapitalen udgør herefter kr. 13.246.070,00.
Vedtægter ændret: 18.12.2020
Revision:
Fratrådte:
PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 19.10.2020.
Tiltrådte:
CVR-NR. 30700228 EY Godkendt Revisionspartnerselskab, Dirch Passers Allé 36, 2000 Frederiksberg, den 19.10.2020.
Vedtægter ændret: 30.09.2020
Kapitalforhøjelsen er besluttet den 30.09.2020.
kr. 676.363,00, indbetalt kontant, kurs 2.200,00. kr. 1.500,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 8.225.977,00.
Direktion:
Fratrådte:
Frans Gustaf Wuite, (adm. dir), den 30.06.2020.
Vedtægter ændret: 28.05.2020
Bestyrelse:
Fratrådte:
Ingelise Saunders, (formand), den 28.05.2020, Paul David Goldenheim, den 28.05.2020.
Tiltrådte:
Jørgen Søberg Petersen, (formand), den 28.05.2020.
Vedtægter ændret: 10.09.2019
Bestyrelse:
Fratrådte:
Stephan Christgau, den 09.09.2019, Duan Xiang, den 09.09.2019.
Tiltrådte:
Morten Døssing, den 09.09.2019, Karen Juo-Lai Chu, den 09.09.2019.
Vedtægter ændret: 11.04.2019
Kapitalforhøjelsen er besluttet den 11.04.2019.
kr. 500.596,00, indbetalt ved konvertering af gæld, kurs 1.400,00. kr. 195.000,00, indbetalt ved konvertering af gæld, kurs 2.000,00.
Kapitalen udgør herefter kr. 7.548.114,00.
Vedtægter ændret: 23.01.2019
Kapitalforhøjelsen er besluttet den 23.01.2019.
kr. 1.697.021,00, indbetalt kontant, kurs 2.200,00.
Kapitalen udgør herefter kr. 6.852.518,00.
Bestyrelse:
Tiltrådte:
Duan Xiang, den 23.01.2019.
Direktion:
Fratrådte:
Lars Jakob Dynnes Hansen, den 01.12.2018.
Tiltrådte:
Torgeir Vaage, den 01.12.2018.
Vedtægter ændret: 22.10.2018
Kapitalforhøjelsen er besluttet den 22.10.2018.
kr. 328.571,00, indbetalt ved konvertering af gæld, kurs 1.400,00. kr. 808.129,00, indbetalt kontant, kurs 2.000,00.
Kapitalen udgør herefter kr. 5.155.497,00.
Bestyrelse:
Tiltrådte:
Ann Mills-Duggan, den 22.10.2018.
Vedtægter ændret: 10.05.2018
Kapitalforhøjelsen er besluttet den 10.05.2018.
kr. 123.000,00, indbetalt ved konvertering af gæld, kurs 1.400,00. kr. 301.301,00, indbetalt kontant, kurs 2.000,00.
Kapitalen udgør herefter kr. 4.018.797,00.
Vedtægter ændret: 26.05.2017
Vedtægter ændret: 17.03.2017
Direktion:
Tiltrådte:
Lars Jakob Dynnes Hansen, den 17.03.2017.
Selskabet tegnes af tre bestyrelsesmedlemmer eller af en direktør og bestyrelsesformanden i forening..
Vedtægter ændret: 21.12.2016
Kapitalforhøjelsen er besluttet den 21.12.2016.
kr. 506.099,00, indbetalt ved konvertering af gæld, kurs 1.400,00.
Kapitalen udgør herefter kr. 3.594.496,00.
Vedtægter ændret: 28.10.2016
Kapitalforhøjelsen er besluttet den 28.10.2016.
kr. 804.790,00, indbetalt kontant, kurs 2.000,00.
Kapitalen udgør herefter kr. 3.088.397,00.
Vedtægter ændret: 14.10.2016
Kapitalforhøjelsen er besluttet den 14.10.2016.
kr. 434.280,00, indbetalt kontant, kurs 1.750,00.
Kapitalen udgør herefter kr. 2.283.607,00.
Direktion:
Fratrådte:
Ulrik Svane Sørensen (adm. dir), den 01.04.2016.
Tiltrådte:
Frans Gustaf Wuite (adm. dir), den 01.04.2016.
Vedtægter ændret: 23.02.2016
Vedtægter ændret: 21.09.2015
CVR-nummer:
34083738.
NAVN:
ACESION PHARMA ApS.
Adresse: Ole Maaløes Vej 3, 2200 København N.
Kommune: København.
CVR-nummer:
34083738.
NAVN:
ACESION PHARMA ApS.
Adresse: Ole Maaløes Vej 3, 2200 København N.
Kommune: København.
Vedtægter ændret: 11.05.2015
Kapitalforhøjelse: kr. 536.305,00, indbetalt ved konvertering af gæld, kurs 1.400,00.
Kapitalen udgør herefter kr. 1.849.327,00.
Vedtægter ændret:
17.12.2014.
Kapitalforhøjelse:
kr. 434.280,00 indbetalt kontant, kurs 1.750,00.
Klasser:
B-anparter kr. 434.280,00.
Kapitalen udgør herefter kr. 1.313.022,00.
Kapitalen er opdelt i klasser:
A-anparter kr. 80.000,00. B-anparter kr. 1.233.022,00.
Vedtægter ændret:
01.08.2014.
Bestyrelse:
Fratrådt som formand, men forbliver i bestyrelsen: Bobby G Soni, den 01.08.2014.
Udtrådt af bestyrelsen:
Frank Knudsen, den 01.08.2014.
Indtrådt i bestyrelsen:
Adm. direktør Ingelise Saunders (formand), den 01.08.2014, Direktør Carsten Schou, den 01.08.2014.
Vedtægter ændret:
04.04.2014.
Kapitalforhøjelse:
kr. 231.600,00 indbetalt kontant, kurs 1.400,00.
Kapitalen udgør herefter kr. 878.742,00.
Kapitalen er opdelt i klasser:
A-anparter kr. 80.000,00. B-anparter kr. 798.742,00.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for ACESION PHARMA ApS:
Have Pro? Sign in.
P-number 1017343668Nordre Fasanvej 215, 2000 Frederiksberg
No other current company drawn.
No other current company drawn.
No other current company drawn.